Metastatic breast cancer can come with many physical changes that can be noticeable and impact daily functioning, but there ...

The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...

Detailed price information for Briacell Therapeutics Corp (BCT-T) from The Globe and Mail including charting and trades.

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS ...

BriaCell Therapeutics Corp. (BCTX, BCTXW) is down by 4.71 percent during Monday morning trading, following the announcement of a ...

BriaCell Therapeutics (TSX:BCT) is reporting that the first metastatic breast cancer patient treated with its Bria-OTS ...

During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast ...

A qualitative study yielded important insights about how patients, caregivers and clinicians define what truly is clinically ...

Therapeutics announces an unprecedented clinical response including resolution of a lung metastasis with stable disease ...